<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17317" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Akinesia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramakrishnan </surname>
            <given-names>Sharanya</given-names>
          </name>
          <aff>Grant Government Medical College and Sir JJ Group of Hospitals</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sharanya Ramakrishnan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17317.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Akinesia or "absent movement" is a clinical sign that could be indicative of a number of disorders, depending on the age group of the patient. The varied heterogeneous pathogenesis must be understood in order to correctly diagnose and manage the underlying disorder. This activity outlines the evaluation, and management of akinesia and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of akinesia.</p></list-item><list-item><p>Discuss the pathophysiology of akinesia.</p></list-item><list-item><p>Outline the management depending on the etiology of akinesia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17317&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17317">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17317.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The term akinesia refers to the inability to perform a clinically perceivable movement. It can present as a delayed response, freezing mid-action, or even total abolition of movement. Akinesia occurs when movement is not perceived either because the amplitude of the movement is small or because the time taken to initiate the reaction is significantly increased. The former is often a consequence of severe bradykinesia, which is commonly mistakenly referred to as akinesia. This makes it difficult to differentiate between the two. In akinesia, there is failure&#x000a0;of a rapid build-up of adequate power to initiate the movement.</p>
        <p>Akinetic states are associated with numerous etiological causes, that vary with the age of the patient. In adults, akinesia can present alone or as sequelae of neurodegenerative disorders.<xref ref-type="bibr" rid="article-17317.r1">[1]</xref><xref ref-type="bibr" rid="article-17317.r2">[2]</xref>&#x000a0;Findings of akinesia noticed antenatally or neonatally is associated with fetal akinesia syndrome.</p>
      </sec>
      <sec id="article-17317.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The causes of akinesia can be classified based on the age group of presentation.</p>
        <p>1. Adult-onset akinesia has been associated with the following two causes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pure isolated akinesia</p>
          </list-item>
          <list-item>
            <p>Late stages of disorders affecting the basal ganglia or frontal lobes
<list list-type="bullet"><list-item><p>Progressive supranuclear palsy (PSP) (also known as&#x000a0;Steele-Richardson-Olszewski syndrome)</p></list-item><list-item><p>Parkinson's disease (PD)</p></list-item><list-item><p>Multiple system atrophy</p></list-item><list-item><p>Normal-pressure hydrocephalus.<xref ref-type="bibr" rid="article-17317.r1">[1]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>2. The fetal akinetic syndrome (fetal arthrogryposis or&#x000a0;Pena&#x02013;Shokeir syndrome type 1), is a cause of intrauterine fetal death or rarely a live birth, related to diffuse contractures across the body (arthrogryposis) of the fetus and subsequently reduced movement, further leading to intrauterine growth restriction, short umbilical cord, and pulmonary hypoplasia.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref></p>
      </sec>
      <sec id="article-17317.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It has been found that akinesia&#x000a0;in clinically observed parkinsonism is more commonly associated with the motor variant of frontotemporal lobe dementia (FTLD), rather than PD related frontal degeneration. Around 30%&#x000a0;of patients with clinically confirmed FTLD showed parkinsonian features, notably, rigidity or akinesia.<xref ref-type="bibr" rid="article-17317.r4">[4]</xref>&#x000a0;Acute akinesia is a relatively rare phenomenon and occurs in 0.3% of patients with PD, secondary to infectious pathology or other stressors.<xref ref-type="bibr" rid="article-17317.r5">[5]</xref>&#x000a0;</p>
        <p>In the pediatric population, akinesia is often associated with the fetal akinetic syndrome. This is associated with high intrauterine mortality. However, the incidence in live births is 1 in 3,000 cases, with over 320 genes implicated in its pathology.<xref ref-type="bibr" rid="article-17317.r6">[6]</xref>&#x000a0;It is more predominant in the Asian, European, and African populations.<xref ref-type="bibr" rid="article-17317.r7">[7]</xref></p>
      </sec>
      <sec id="article-17317.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of akinesia in adults broadly appears to stem from pallidonigroluysian degeneration that predominantly leads to freezing.<xref ref-type="bibr" rid="article-17317.r1">[1]</xref>&#x000a0;However, the specific pathology depends on the type of akinesia. In cases with pure akinesia with gait freezing without any other symptom or diagnosis of PD, it is most likely related to PSP. Evidence of degeneration in the subthalamic nuclei, globus pallidus, and substantia nigra are related to PSP.<xref ref-type="bibr" rid="article-17317.r8">[8]</xref><xref ref-type="bibr" rid="article-17317.r9">[9]</xref>&#x000a0;</p>
        <p>In patients with PD, the principal cause of akinesia appears to be a dysfunction in phasic and tonic dopamine release. This is in contrast to resting tremors caused mainly due to a dysfunctional tonic phase of dopamine release.<xref ref-type="bibr" rid="article-17317.r10">[10]</xref>&#x000a0;Another theory suggests that the akinesia in PD patients is related to bilateral frontal involvement and is also accompanied by deteriorating mental states.<xref ref-type="bibr" rid="article-17317.r11">[11]</xref></p>
        <p>Fetal akinesia has been associated with around 320 genetic variations that could all present with this syndrome. Pathologically speaking, the pathology is evident at all levels, including the&#x000a0;brain, spinal cord, motor neuron, neuromuscular junction, and the muscle.<xref ref-type="bibr" rid="article-17317.r12">[12]</xref></p>
      </sec>
      <sec id="article-17317.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In PD, the examination of a patient with akinesia would reveal freezing mid-movement, festination of both gait and&#x000a0;speech, and repetitive upper limb movements.<xref ref-type="bibr" rid="article-17317.r1">[1]</xref>&#x000a0;This freezing is typically associated with exaggeration of symptoms with&#x000a0;ambulation through narrow spaces like doorways.<xref ref-type="bibr" rid="article-17317.r13">[13]</xref>&#x000a0;This usually does not respond to antiparkinson medication.</p>
        <p>In akinetic patients secondary to PSP, the rigidity is mainly axial rather than appendicular. The earliest manifestation occurs with recurrent falls, due to profound rigidity, but atypical manifestations like&#x000a0;non-specific dizziness, generalized motor slowing, and personality change, could also be present.&#x000a0;Slowing of vertical saccades is the most common eye movement manifestation, along with difficulty in down-gazing.<xref ref-type="bibr" rid="article-17317.r14">[14]</xref></p>
        <p>Antenatally, a patient carrying a fetus with possible fetal akinesia can present with reduced fetal movement. Later in the pregnancy, the patient presents with polyhydramnios, evidenced by abnormally increased fundal height.</p>
        <p>In a live birth with fetal akinesia syndrome, the following sequence is often observed as a result of a lack of fetal movement.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Fetal joint contractures</p>
          </list-item>
          <list-item>
            <p>Pulmonary hypoplasia</p>
          </list-item>
          <list-item>
            <p>Polyhydramnios</p>
          </list-item>
          <list-item>
            <p>Micrognathia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17317.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The determination of akinesia in a patient is mainly clinical and characterized by a delay or inability to react or execute a motor command. Quantitatively, reaction time studies are used to assess the degree of akinesia. It typically reveals a delay in simple reaction time, but a normal choice reaction time.<xref ref-type="bibr" rid="article-17317.r2">[2]</xref></p>
        <p>The neuroimaging studies employed in the assessment of akinesia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Magnetic resonance imaging (MRI)</p>
          </list-item>
          <list-item>
            <p>Functional MRI</p>
          </list-item>
          <list-item>
            <p>Single-photon emission computed tomography</p>
          </list-item>
          <list-item>
            <p>Positron emission tomography</p>
          </list-item>
        </list>
        <p>In patients with akinesia-rigidity dominant PD, in comparison to a tremor-dominant variant, a higher global functional connective density (FCD) in the akinetic-rigid dominant variant is in the left inferior frontal gyrus, right middle frontal gyrus, right superior frontal gyrus along with a&#x000a0;lower global FCD in the&#x000a0;akinetic-rigid dominant left cerebellum anterior lobule.<xref ref-type="bibr" rid="article-17317.r15">[15]</xref></p>
        <p>Pure akinesia with gait freezing, associated with PSP, has imaging findings showing significant cortical thinning in inferior bilateral frontal, left orbitofrontal, right anterior cingulate, bilateral insula, bilateral supramarginal, right angular and precunial, and bilateral temporal areas, often involving the parahippocampal and lingual gyri.<xref ref-type="bibr" rid="article-17317.r16">[16]</xref>&#x000a0;The MRI can show midbrain atrophy with the classic&#x000a0;hummingbird sign or the morning glory sign with loss of the lateral convex margin of the tegmentum. Patients have&#x000a0;diffuse Tau protein aggregates in the basal ganglia on histopathology.</p>
        <p>The current imaging strategies do not give any information on the neurotransmitter type involved in the disorder's pathogenesis. Futuristic models are likely to conduct pharmacological imaging, complex behavioral tasks along with movement analysis techniques, allowing practitioners to quantify the akinesia.<xref ref-type="bibr" rid="article-17317.r15">[15]</xref></p>
        <p>A presumptive diagnosis of fetal akinesia is made after obtaining a normal karyotype and excluding other conditions. Antenatal diagnosis can be carried out as early as 12 weeks of gestation after clinically presenting with reduced fetal movement, fetal edema, or fixed limb posturing, as observed on antenatal ultrasonography.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref></p>
      </sec>
      <sec id="article-17317.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of akinesia in adults revolves around controlling the progression of the underlying disease.&#x000a0;The management of akinesia is symptomatic rather than curative.</p>
        <list list-type="bullet">
          <list-item>
            <p>Drug therapy: In patients with PD, this mainly aims to modify/supplement the impaired dopamine release.</p>
          </list-item>
          <list-item>
            <p>Progressive resistance exercise is useful in improving symptoms of an improved static posturography, gait, and the general quality of living in patients with an akinetic rigid variant of PD.<xref ref-type="bibr" rid="article-17317.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Surgical therapy: The most studied surgical procedure aiding in the management of akinesia is deep brain stimulation, typically used to improve dopamine secretion and improve symptoms of tremors, akinesia, and rigidity.</p>
          </list-item>
          <list-item>
            <p>Other procedures performed in severe cases include thalamotomy, pallidotomy, neural implants, and electrical stimulation.</p>
          </list-item>
        </list>
        <p>The treatment for fetal akinesia is supportive mainly due to a dismal prognosis in a live birth. Resuscitative measures are initially employed to combat pulmonary hypoplasia. Medications like sildenafil and iloprost to control raised pulmonary pressures are initially used. They can still be converted to a less life-sustaining comfort care approach after adequate discussions with the parents. Antimicrobials may be required. Prolonged parental nutrition is often needed in these patients due to malrotation of gut, short-gut syndrome, and impaired swallowing. Central nervous system anomalies like seizures and endocrine disorders like hypothyroidism need treatment with anticonvulsants and thyroid hormone replacements.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref></p>
      </sec>
      <sec id="article-17317.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Adult akinesia should be differentiated from:</p>
        <list list-type="order">
          <list-item>
            <p>Catatonia: These patients are predominantly apathetic and present with posturing rather than difficulty initiating movement.</p>
          </list-item>
          <list-item>
            <p>Akinesia arrest reaction: This is typically intermittent in onset, associated with seizure activity on electroencephalogram.<xref ref-type="bibr" rid="article-17317.r11">[11]</xref></p>
          </list-item>
        </list>
        <p>Live births with fetal akinesia syndrome should be differentiated from:</p>
        <list list-type="order">
          <list-item>
            <p>Osteogenesis imperfecta: This is typically associated with multiple fractures, not accompanied by contractures, unlike fetal akinesia syndrome. Other findings, like&#x000a0;blue sclera, conductive deafness, and mild stunting, would make this diagnosis more likely.<xref ref-type="bibr" rid="article-17317.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Potter's sequence: This is often associated with renal agenesis, but not with contractures.</p>
          </list-item>
          <list-item>
            <p>Congenital myopathies: This is not frequently associated with intrauterine death, but is associated with gradually progressing muscle weakness.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Congenital myasthenia gravis: An infant with congenital myasthenia would present with ptosis, poor crying and sucking reflex,&#x000a0;and facial, bulbar, and generalized weakness.<xref ref-type="bibr" rid="article-17317.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Maternal antibodies to fetal acetylcholine receptor: A history of myasthenia present in the mother, would make this a more likely diagnosis.</p>
          </list-item>
          <list-item>
            <p>Metabolic disorders: Mucopolysaccharidosis III, glycosylation type 1A deficiency, phosphofructokinase deficiency (glycogenosis VII)</p>
          </list-item>
          <list-item>
            <p>Trisomy 18:&#x000a0;Other midline defects like holoprosencephaly, omphalocele, cleft lip/palate would also be present in this disorder.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17317.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Adult-onset akinesia has no curative therapy, but symptomatic treatment can significantly alter the damage done to the quality of life in these patients. Although a mild variant of akinesia cannot directly lead to death, severe forms of akinetic crises can cause dysphagia, autonomic dysfunction, and aspiration, which can prove fatal.</p>
        <p>Fetal akinesia syndrome has been primarily found to be lethal in utero, with 30% of fetuses being stillborn. The ultimate prognosis is dependent on the underlying cause. The majority of live-born infants usually die within the first month of life. This could warrant an offer for the late termination of pregnancy in countries that allow it.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref></p>
      </sec>
      <sec id="article-17317.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Fetal akinesia is often lethal within the first month of life. This is due to the many complications associated with this condition.</p>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary complications: Pulmonary hypoplasia, pulmonary hypertension, aspiration pneumonia.</p>
          </list-item>
          <list-item>
            <p>Oropharyngeal dysfunction: This leads to aspiration and subsequent pneumonia.</p>
          </list-item>
          <list-item>
            <p>Neurological complications: Seizures and hypothalamic dysfunction.</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal complications: Short gut syndrome and intestinal malrotation.</p>
          </list-item>
          <list-item>
            <p>Endocrine dysfunction: Hypothyroidism from hypothalamic dysfunction.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>Akinesia in adults can often present as an emergency, known as akinetic crises. Parkinsonian hyperpyrexia, neuroleptic-like malignant syndrome, acute akinesia, and malignant syndrome in parkinsonism are other terms used to describe these akinetic crises. This variant spectrum may vary from&#x000a0;total akinesia with dysphagia, hyperthermia, dysautonomia, the increment of muscle enzymes, and alterations of mental status, to only, the inability or difficulty in initiating movement.<xref ref-type="bibr" rid="article-17317.r20">[20]</xref></p>
      </sec>
      <sec id="article-17317.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations will be required from neurologist, movement disorder specialist, physical therapy and rehabilitation, and neurosurgeon.</p>
      </sec>
      <sec id="article-17317.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Adult-onset akinesia creates many challenges for both the patient and the family. Since the supportive treatment like physiotherapy and exercise therapy is primarily motivation driven, it is essential to counsel and encourage patients to seek and diligently follow through with it, over a prolonged period. Of importance, is the underlying depressive episode in these patients. Adequate counseling and medication in clinically depressed patients, a condition not uncommon in Parkinson disease and Parkinson plus syndromes, cannot be stressed upon enough.</p>
        <p>In parents with a live/stillbirth suggestive of fetal akinesia syndrome, fetal surveillance in subsequent pregnancies is essential. An in utero detection will allow for early termination as an option for the parents. The phenotypic condition is derived from various causes, making the recurrence risk calculation less precise. The stipulated recurrence risk lies anywhere between 0% to 25%.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref>&#x000a0;Less life-sustaining comfort care approach after adequate discussions with the parents can be initiated.</p>
      </sec>
      <sec id="article-17317.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Akinesia refers to the inability to perform a clinically perceivable movement</p>
          </list-item>
          <list-item>
            <p>It occurs because the time taken to initiate the reaction is significantly increased, preventing a rapid build-up of adequate power from starting the movement.</p>
          </list-item>
          <list-item>
            <p>Adult-onset akinesia can present as pure isolated akinesia or in late stages of disorders affecting the basal ganglia or frontal lobes.</p>
          </list-item>
          <list-item>
            <p>Fetal akinesia syndrome has been primarily found to be lethal in utero. However, the rate of disease in live births is 1 in 3000 cases.</p>
          </list-item>
          <list-item>
            <p>In parents with a live/stillbirth suggestive of fetal akinesia syndrome, fetal surveillance in subsequent pregnancies is essential.</p>
          </list-item>
          <list-item>
            <p>Akinesia in adults can often present as an emergency, known as akinetic crises, which include dysphagia, hyperthermia, dysautonomia, the increment of muscle enzymes, and alterations of mental status.</p>
          </list-item>
          <list-item>
            <p>The management of akinesia is supportive rather than curative.</p>
          </list-item>
          <list-item>
            <p>Progressive resistance exercise is useful in improving symptoms of an improved static posturography and gait in the akinetic rigid variant of Parkinson disese.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17317.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team is of utmost importance in providing the best possible outcome both physically and psychologically, for patients with akinesia and their family. While the diagnosis of adult-onset akinesia is dependent on the neurologist, fetal akinesia can be appreciated by an obstetrician and fetal medicine specialist. The rehabilitation of akinesia in adults is heavily dependent on self-motivation and requires regular counseling and psychological evaluation. On the other hand, the parents of a live-born with akinesis, with potentially lethal etiologies, must be counseled and supported when opting for comfort care. Surgeons of numerous disciplines and neonatologists play a role in providing structural and functional corrections in these patients.<xref ref-type="bibr" rid="article-17317.r3">[3]</xref>&#x000a0;</p>
        <p>The nurse and the pharmacist are responsible for dispensing the right medication and dosage. Finally, physiotherapists' role cannot be undermined in both fetal and adult akinesia as they contribute to significantly improving the quality of life in these patients.</p>
        <p>Collaboration shared decision making, and communication&#x000a0;is crucial for a good outcome. The interprofessional care must use an integrated care pathway using an evidence-based.&#x000a0;The earlier signs and symptoms of a complication&#x000a0;are identified, the better is the prognosis and outcome.</p>
      </sec>
      <sec id="article-17317.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17317&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17317">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/akinesia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17317">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17317/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17317">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17317.s17">
        <title>References</title>
        <ref id="article-17317.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkouzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bit-Ivan</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Elble</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Pure akinesia with gait freezing: a clinicopathologic study.</article-title>
            <source>J Clin Mov Disord</source>
            <year>2017</year>
            <volume>4</volume>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">29051824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hallett</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical neurophysiology of akinesia.</article-title>
            <source>Rev Neurol (Paris)</source>
            <year>1990</year>
            <volume>146</volume>
            <issue>10</issue>
            <fpage>585</fpage>
            <page-range>585-90</page-range>
            <pub-id pub-id-type="pmid">2263821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coetzee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Honey</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Pena-Shokeir syndrome: current management strategies and palliative care.</article-title>
            <source>Appl Clin Genet</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>111</fpage>
            <page-range>111-120</page-range>
            <pub-id pub-id-type="pmid">30498368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>New perspective on parkinsonism in frontotemporal lobar degeneration.</article-title>
            <source>J Mov Disord</source>
            <year>2013</year>
            <month>May</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">24868417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simonetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferigo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zanet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Capus</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Antonutti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zorzon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pizzolato</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acute Akinesia, an unusual complication in Parkinson's Disease: a case report.</article-title>
            <source>Neurol Sci</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-3</page-range>
            <pub-id pub-id-type="pmid">18612768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niles</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Blaser</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shannon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chitayat</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Fetal arthrogryposis multiplex congenita/fetal akinesia deformation sequence (FADS)-Aetiology, diagnosis, and management.</article-title>
            <source>Prenat Diagn</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>720</fpage>
            <page-range>720-731</page-range>
            <pub-id pub-id-type="pmid">31218730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skaria</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Arthrogryposis multiplex congenita in utero: radiologic and pathologic findings.</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>502</fpage>
            <page-range>502-511</page-range>
            <pub-id pub-id-type="pmid">28954562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Holton</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Strand</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Revesz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lees</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.</article-title>
            <source>Mov Disord</source>
            <year>2007</year>
            <month>Nov</month>
            <day>15</day>
            <volume>22</volume>
            <issue>15</issue>
            <fpage>2235</fpage>
            <page-range>2235-41</page-range>
            <pub-id pub-id-type="pmid">17712855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsuo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kishikawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsujihata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagataki</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pure akinesia: an atypical manifestation of progressive supranuclear palsy.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1991</year>
            <month>May</month>
            <volume>54</volume>
            <issue>5</issue>
            <fpage>397</fpage>
            <page-range>397-400</page-range>
            <pub-id pub-id-type="pmid">1865200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caligiore</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mannella</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baldassarre</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Different Dopaminergic Dysfunctions Underlying Parkinsonian Akinesia and Tremor.</article-title>
            <source>Front Neurosci</source>
            <year>2019</year>
            <volume>13</volume>
            <fpage>550</fpage>
            <pub-id pub-id-type="pmid">31191237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niedermeyer</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Akinesia and the frontal lobe.</article-title>
            <source>Clin EEG Neurosci</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-42</page-range>
            <pub-id pub-id-type="pmid">18318418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ravenscroft</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sollis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>North</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Baynam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Laing</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Fetal akinesia: review of the genetics of the neuromuscular causes.</article-title>
            <source>J Med Genet</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>48</volume>
            <issue>12</issue>
            <fpage>793</fpage>
            <page-range>793-801</page-range>
            <pub-id pub-id-type="pmid">21984750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shine</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gilat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ehgoetz Martens</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Moustafa</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Naismith</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>SJG</given-names>
              </name>
            </person-group>
            <article-title>Identifying the neural correlates of doorway freezing in Parkinson's disease.</article-title>
            <source>Hum Brain Mapp</source>
            <year>2019</year>
            <month>May</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>2055</fpage>
            <page-range>2055-2064</page-range>
            <pub-id pub-id-type="pmid">30637883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Progressive Supranuclear Palsy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>27</day>
            <pub-id pub-id-type="pmid">30252354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Welter</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Boulinguez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ballanger</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Functional imaging correlates of akinesia in Parkinson's disease: Still open issues.</article-title>
            <source>Neuroimage Clin</source>
            <year>2019</year>
            <volume>21</volume>
            <fpage>101644</fpage>
            <pub-id pub-id-type="pmid">30584015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hong</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Sunwoo</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Ham</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Comparison of regional brain atrophy and cognitive impairment between pure akinesia with gait freezing and Richardson's syndrome.</article-title>
            <source>Front Aging Neurosci</source>
            <year>2015</year>
            <volume>7</volume>
            <fpage>180</fpage>
            <pub-id pub-id-type="pmid">26483680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fernandez-Rio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Winge</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Barrag&#x000e1;n-P&#x000e9;rez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-G&#x000f3;mez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-D&#x000ed;ez</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Luc&#x000ed;a</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iglesias-Soler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dopico-Calvo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Del-Olmo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Del-Valle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanco-Traba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suman</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-G&#x000f3;mez</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effects of progressive resistance exercise in akinetic-rigid Parkinson's disease patients: a randomized controlled trial.</article-title>
            <source>Eur J Phys Rehabil Med</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>651</fpage>
            <page-range>651-663</page-range>
            <pub-id pub-id-type="pmid">28290191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Subramanian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anastasopoulou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Viswanathan</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <chapter-title>Osteogenesis Imperfecta</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>2</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">30725642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Abicht</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lochm&#x000fc;ller</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Congenital Myasthenic Syndromes Overview</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2003</year>
            <month>5</month>
            <day>9</day>
            <pub-id pub-id-type="pmid">20301347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17317.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Onofrj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonanni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cossu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Manca</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stocchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.</article-title>
            <source>Parkinsonism Relat Disord</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>15 Suppl 3</volume>
            <fpage>S233</fpage>
            <page-range>S233-6</page-range>
            <pub-id pub-id-type="pmid">20082998</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
